378
Views
6
CrossRef citations to date
0
Altmetric
Review

Emerging role of GLP-1 receptor agonists in the treatment of obesity

&
Pages 263-273 | Published online: 27 Sep 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Eva Winning Iepsen, Signe Sørensen Torekov & Jens Juul Holst. (2015) Liraglutide for Type 2 diabetes and obesity: a 2015 update. Expert Review of Cardiovascular Therapy 13:7, pages 753-767.
Read now
Eva W Iepsen, Signe S Torekov & Jens J Holst. (2014) Therapies for inter-relating diabetes and obesity – GLP-1 and obesity. Expert Opinion on Pharmacotherapy 15:17, pages 2487-2500.
Read now

Articles from other publishers (4)

Abby Fornes, Jamie Huff, Roger Iain Pritchard & Miranda Godfrey. (2022) Once-Weekly Semaglutide for Weight Management: A Clinical Review. Journal of Pharmacy Technology 38:4, pages 239-246.
Crossref
Ianosi Edith Simona, Comes Alexandra & Jimborean Gabriela. (2015) Obesity Treatment Strategies. Acta Medica Marisiensis 61:4, pages 361-366.
Crossref
I. J. Martins, Rhona Creegan, W. L. F. Lim & R. N. Martins. (2013) Molecular Insights into Appetite Control and Neuroendocrine Disease as Risk Factors for Chronic Diseases in Western Countries. Open Journal of Endocrine and Metabolic Diseases 03:05, pages 11-33.
Crossref
George Bray. 2011. A Guide to Obesity and the Metabolic Syndrome. A Guide to Obesity and the Metabolic Syndrome 283 360 .